021-51111890
购物车（）
sales@molnova.cn
NAN-190 hydrobromide
CAS No. 115338-32-4
NAN-190 hydrobromide ( NAN190 hydrobromide;NAN 190 hydrobromide )
产品货号. M10539 CAS No. 115338-32-4
NAN-190 is a 5-HT1A receptor antagonist with Ki of 0.6 nM; also potently blocks the α2-adrenergic receptor.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥259 | 有现货 |
|
| 10MG | ￥373 | 有现货 |
|
| 50MG | ￥599 | 有现货 |
|
| 100MG | ￥778 | 有现货 |
|
| 200MG | ￥1401 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称NAN-190 hydrobromide
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述NAN-190 is a 5-HT1A receptor antagonist with Ki of 0.6 nM; also potently blocks the α2-adrenergic receptor.
-
产品描述NAN-190 is a 5-HT1A receptor antagonist with Ki of 0.6 nM; also potently blocks the α2-adrenergic receptor; antagonizes the stimulation by norepinephrine of phosphoinositide turnover in rat cortical slices.Anxiety Preclinical
-
同义词NAN190 hydrobromide;NAN 190 hydrobromide
-
通路Endocrinology/Hormones
-
靶点5-HT Receptor
-
受体5-HT Receptor
-
研究领域Neurological Disease
-
适应症Anxiety
化学信息
-
CAS Number115338-32-4
-
分子量474.39
-
分子式C23H28BrN3O3
-
纯度>98% (HPLC)
-
溶解度DMSO: 36.23 mg/mL
-
SMILESCOC1=CC=CC=C1N2CCN(CC2)CCCCN3C(=O)C4=CC=CC=C4C3=O.Br
-
化学全称1H-Isoindole-1,3(2H)-dione, 2-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]-, hydrobromide (1:1)
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Claustre Y, et al. Eur J Pharmacol. 1991 Oct 29;204(1):71-7.
2. Zhang J, et al. J Neurosci. 2010 Feb 17;30(7):2433-41.
3. Glennon RA, et al. J Med Chem. 1988 Oct;31(10):1968-71.
2. Zhang J, et al. J Neurosci. 2010 Feb 17;30(7):2433-41.
3. Glennon RA, et al. J Med Chem. 1988 Oct;31(10):1968-71.
产品手册
关联产品
-
JNJ-5234801
JNJ-5234801 is an atypical anxiolytic targeting 5-HT2 receptor, has demonstrated oral activity in animal models of anxiety.
-
Risperidone
An antipsychotic agent with serotonin-S2 and dopamine-D2 antagonistic properties.
-
8-Hydroxy-DPAT hydro...
8-Hydroxy-DPAT hydrobromide (8-OH-DPAT hydrobromide) is a potent and selective 5-HT1A agonist with a pIC50 of 8.19. 8-Hydroxy-DPAT hydrobromide has a selectivity of almost 1000 fold for a subtype of the 5-HT1 binding site.
